CVE-2020-16198
MEDIUMCVSS 6.3/10EPSS 0.53%
Last modified
CVE-2020-16198 is a medium-severity vulnerability rated 6.3/10 on the CVSS scale. When an attacker claims to have a given identity, Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not prove or insufficiently proves the claim is correct.. EPSS estimates a 0.53% chance of exploitation in the next 30 days.
Description
When an attacker claims to have a given identity, Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not prove or insufficiently proves the claim is correct.
Metrics
CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Philips | Clinical Collaboration Platform | <= 12.2.1 |
References
- https://us-cert.cisa.gov/ics/advisories/icsma-20-261-01Third Party Advisory, US Government Resource
- https://us-cert.cisa.gov/ics/advisories/icsma-20-261-01Third Party Advisory, US Government Resource
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2020-16198?
When an attacker claims to have a given identity,
Philips Clinical Collaboration Platform, Versions 12.2.1 and prior,
does not prove or insufficiently proves the claim is correct.
How severe is CVE-2020-16198?
CVE-2020-16198 has a CVSS score of 6.3/10 (MEDIUM severity). The EPSS model estimates a 0.53% probability of exploitation in the next 30 days.
How do I fix CVE-2020-16198?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.
Are you affected by CVE-2020-16198?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST